P740: PK, PD AND SAFETY OF FIRST-IN-HUMAN, FIRST-IN-CLASS PHASE I TRIAL (AUR103-101; BHARAT) OF AUR103, AN ORAL CD47 INHIBITOR, IN PATIENTS WITH ADVANCED MALIGNANCIES

por Krishnappa, Manjunath, Mandavia, Divyesh, Jain, Minish, S, Mukesh, Patel, Ankit, Agarwal, Anshul, Giri, Sanjeev, Kumar Tiwari, Nirbhay, Thiyagarajan, Saravanan, Dey, Mamon, Padmanabha Naidu, Gutta, Ramachandra, Murali, Kumar, Akhil
Publicado 2023